Jon Bouffard

Feb 28, 2023 | ajp.com.au | Jon Bouffard |Big John |Michael Hewson |Megan Haggan

Vitamins A, D, E and K are fat-soluble vitamins. Knowledge of their physiological function provides a better understanding of the effects and risk factors for deficiency when considering which vitamin supplements are appropriate for a particular patient, writes Chrysa Giannellis. Chrysa Giannellis is a consultant pharmacist and managing director of Hummingbird Pharmaceutical Consulting. Learning ObjectivesThis content is restricted to registered users only.

Feb 28, 2023 | ajp.com.au | Louis Roller |Jenny Gowan |Jon Bouffard |Big John

Facial pain is a common and often debilitating condition. This article explores some common types and causes of facial pain. It also discusses various treatments including appropriate use of medicines for treating trigeminal neuralgia. By Dr Louis Roller PhD, MSc, BPharm, BSc, Dip Ed, FPS, FACPP and Dr Jenny Gowan PhD, Grad Dip Comm Pharm,This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Feb 28, 2023 | ajp.com.au | Karalyn Huxhagen |Jon Bouffard |Big John |Michael Hewson

Pharmacists have a key role in identifying persons who may be experiencing exercise-induced bronchoconstriction. By Karalyn Huxhagen BPharm, FPS, AACPA, community pharmacist and accredited consultant pharmacist Learning Objectives After completing this activity, pharmacists should be able to: discuss the physiology of exercise-induced bronchoconstriction (EIB); identify triggers that contribute to EIB; create an asthma action planThis content is restricted to registered users only.

Feb 28, 2023 | ajp.com.au | Debbie Rigby |Big John |Michael Hewson |Jon Bouffard

Optimal management of COPD should include identification and management of comorbidities. As COPD has a high rate of comorbidity with cardiovascular disease, patients with COPD may benefit from cardioprotective medications when indicated. Pharmacists conducting medication reviews for patients with COPD should consider a cardiovascular risk assessment. By Debbie Rigby, advanced practice pharmacist Learning Objectives AfterThis content is restricted to registered users only.